Related Experiment Video
Updated: May 31, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Adoptive cell therapy for patients with melanoma
1Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892-1201, USA.
Journal of Cancer
|July 1, 2011
Summary
Adoptive cell therapy using tumor infiltrating lymphocytes (TIL) and gene-engineered T cells shows promise for advanced cancers. Clinical trials investigate these novel immunotherapies for melanoma and other solid tumors.
Area of Science:
- Oncology
- Immunotherapy
- Cellular Therapy
Background:
- Advanced cancers, including melanoma and other solid tumors, present significant treatment challenges.
- Adoptive cell therapy (ACT) offers a potential therapeutic strategy for refractory malignancies.
- Tumor-infiltrating lymphocytes (TIL) and gene-engineered T cells are key components of advanced ACT approaches.
Purpose of the Study:
- To summarize clinical trial findings on ACT for advanced cancers.
- To evaluate the efficacy of TIL and gene-engineered T cells in patients with melanoma and other solid tumors.
- To report on research conducted at the National Cancer Institute (NCI) Surgery Branch.
Main Methods:
- Investigating tumor-infiltrating lymphocytes (TIL) therapy.
- Utilizing gene-engineered peripheral blood T cells.
- Analyzing clinical trial data from patients with advanced solid tumors.
Main Results:
- Adoptive cell therapy demonstrates effectiveness in select patients with advanced cancer.
- TIL and gene-engineered T cell therapies are being actively investigated in clinical trials.
- The NCI Surgery Branch is a key site for this research.
Conclusions:
- Adoptive cell therapy, particularly with TIL and engineered T cells, holds significant therapeutic potential.
- Further clinical investigation is warranted to optimize these immunotherapies for broader application.
- These cellular therapies represent a promising frontier in the treatment of advanced solid tumors.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...